Addressing immune-related adverse events of cancer immunotherapy: how prepared are rheumatologists?

Ann Rheum Dis. 2019 Jun;78(6):860-862. doi: 10.1136/annrheumdis-2018-214748. Epub 2019 Jan 18.
No abstract available

Keywords: PD-1; T Cells; arthritis; autoimmunity; inflammation; multidisciplinary team-care.

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents, Immunological / adverse effects
  • Autoimmune Diseases / etiology
  • Clinical Competence*
  • Humans
  • Immunotherapy / adverse effects*
  • Inflammation / etiology
  • Neoplasms / therapy*
  • Rheumatologists / standards*

Substances

  • Antineoplastic Agents, Immunological